<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of a type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> subject who developed severe <z:e sem="disease" ids="C0023530" disease_type="Disease or Syndrome" abbrv="">leucopenia</z:e> associated with treatment with the dipeptidil-peptidase 4 enzyme inhibitor <z:chebi fb="0" ids="40237">Sitagliptin</z:chebi> and highlights DPP4 inhibitors as a possible cause of unexplained hematolgical abnormalities in patients receiving DPP4-inhibitor treatment </plain></SENT>
</text></document>